$1.63 Billion is the total value of Eventide Asset Management's 129 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 15.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | CELGENE CORP | $69,278,000 | -1.5% | 702,400 | 0.0% | 4.24% | +7.9% | |
| LRCX | Buy | LAM RESEARCH CORP | $56,160,000 | +2.1% | 668,100 | +0.3% | 3.44% | +11.8% |
| CCI | Buy | CROWN CASTLE INTL CORP NEW | $53,347,000 | +17.6% | 525,950 | +0.3% | 3.26% | +28.8% |
| MIC | Buy | MACQUARIE INFRASTRUCTURE COR | $52,849,000 | +10.3% | 713,700 | +0.4% | 3.23% | +20.8% |
| LOW | Sell | LOWES COS INC | $52,648,000 | -4.8% | 665,000 | -9.0% | 3.22% | +4.2% |
| ABBV | Buy | ABBVIE INC | $51,364,000 | +8.8% | 829,650 | +0.4% | 3.14% | +19.1% |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $44,873,000 | -4.4% | 1,085,200 | -6.1% | 2.75% | +4.7% |
| LEA | LEAR CORP | $44,673,000 | -8.5% | 439,000 | 0.0% | 2.73% | +0.3% | |
| XPO | XPO LOGISTICS INC | $42,497,000 | -14.5% | 1,618,300 | 0.0% | 2.60% | -6.3% | |
| MBBYF | MOBILEYE N V AMSTELVEEN | $40,317,000 | +23.7% | 873,800 | 0.0% | 2.47% | +35.5% | |
| KAR | Sell | KAR AUCTION SVCS INC | $37,787,000 | -17.7% | 905,300 | -24.8% | 2.31% | -9.9% |
| STLD | Sell | STEEL DYNAMICS INC | $36,517,000 | +7.0% | 1,490,500 | -1.6% | 2.24% | +17.3% |
| SPLK | SPLUNK INC | $35,661,000 | +10.7% | 658,200 | 0.0% | 2.18% | +21.2% | |
| CYBR | CYBERARK SOFTWARE LTD | $34,013,000 | +14.0% | 700,000 | 0.0% | 2.08% | +24.8% | |
| SGEN | SEATTLE GENETICS INC | $33,763,000 | +15.2% | 835,506 | 0.0% | 2.07% | +26.1% | |
| PFPT | PROOFPOINT INC | $31,097,000 | +17.3% | 492,900 | 0.0% | 1.90% | +28.5% | |
| ASML | ASML Holding NV | $31,023,000 | -1.2% | 312,700 | 0.0% | 1.90% | +8.2% | |
| ATHN | ATHENAHEALTH INC | $27,768,000 | -0.6% | 201,200 | 0.0% | 1.70% | +8.9% | |
| PANW | Sell | PALO ALTO NETWORKS INC | $27,594,000 | -53.5% | 225,000 | -38.1% | 1.69% | -49.0% |
| FSLR | Buy | FIRST SOLAR INC | $27,391,000 | +300.0% | 565,000 | +465.0% | 1.68% | +337.6% |
| MGA | Buy | MAGNA INTL INC | $25,864,000 | -17.5% | 737,500 | +1.1% | 1.58% | -9.6% |
| IPHI | INPHI CORP | $25,595,000 | -3.9% | 799,100 | 0.0% | 1.57% | +5.2% | |
| WAB | WABTEC CORP | $24,581,000 | -11.4% | 350,000 | 0.0% | 1.50% | -3.0% | |
| WBC | WABCO HLDGS INC | $23,405,000 | -14.4% | 255,600 | 0.0% | 1.43% | -6.2% | |
| BLUE | BLUEBIRD BIO INC | $23,355,000 | +1.9% | 539,500 | 0.0% | 1.43% | +11.6% | |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $23,111,000 | -31.7% | 1,950,276 | +4.6% | 1.41% | -25.3% |
| CPN | Sell | CALPINE CORP | $22,568,000 | -19.3% | 1,530,000 | -17.0% | 1.38% | -11.6% |
| IDTI | INTEGRATED DEVICE TECHNOLOGY | $21,070,000 | -1.5% | 1,046,700 | 0.0% | 1.29% | +7.9% | |
| SYNA | SYNAPTICS INC | $20,989,000 | -32.6% | 390,500 | 0.0% | 1.28% | -26.2% | |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $20,139,000 | +11.8% | 662,900 | +0.0% | 1.23% | +22.3% |
| PEGI | Buy | PATTERN ENERGY GROUP INCcl a | $19,766,000 | +21.7% | 860,500 | +1.1% | 1.21% | +33.4% |
| MGNX | MACROGENICS INC | $19,589,000 | +43.9% | 725,800 | 0.0% | 1.20% | +57.8% | |
| CRUS | CIRRUS LOGIC INC | $19,395,000 | +6.5% | 500,000 | 0.0% | 1.19% | +16.7% | |
| ARW | New | ARROW ELECTRS INC | $18,261,000 | – | 295,000 | +100.0% | 1.12% | – |
| CAFD | Buy | 8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt | $18,115,000 | +9.1% | 1,146,500 | +1.5% | 1.11% | +19.5% |
| LOXO | LOXO ONCOLOGY INC | $17,153,000 | -15.2% | 740,000 | 0.0% | 1.05% | -7.1% | |
| AY | New | ATLANTICA YIELD PLC | $16,990,000 | – | 914,400 | +100.0% | 1.04% | – |
| CBI | CHICAGO BRIDGE & IRON CO N V | $16,913,000 | -5.4% | 488,400 | 0.0% | 1.04% | +3.6% | |
| STKL | SUNOPTA INC | $16,059,000 | -6.0% | 3,832,600 | 0.0% | 0.98% | +2.9% | |
| NVAX | NOVAVAX INC | $15,846,000 | +40.9% | 2,179,700 | 0.0% | 0.97% | +54.5% | |
| EXR | Sell | EXTRA SPACE STORAGE INC | $15,732,000 | -32.7% | 170,000 | -32.0% | 0.96% | -26.3% |
| SPWR | SUNPOWER CORP | $15,490,000 | -30.7% | 1,000,000 | 0.0% | 0.95% | -24.0% | |
| XLRN | Buy | ACCELERON PHARMA INC | $14,574,000 | +30.4% | 428,900 | +1.3% | 0.89% | +42.9% |
| LLTC | LINEAR TECHNOLOGY CORP | $13,615,000 | +4.4% | 292,600 | 0.0% | 0.83% | +14.3% | |
| DATA | Sell | TABLEAU SOFTWARE INCcl a | $13,208,000 | -22.7% | 270,000 | -27.5% | 0.81% | -15.4% |
| BWA | Sell | BORGWARNER INC | $12,989,000 | -31.2% | 440,000 | -10.6% | 0.80% | -24.7% |
| AGIO | AGIOS PHARMACEUTICALS INC | $12,602,000 | +3.2% | 300,800 | 0.0% | 0.77% | +13.0% | |
| ORA | Buy | ORMAT TECHNOLOGIES INC | $12,295,000 | +6.3% | 280,959 | +0.2% | 0.75% | +16.4% |
| SUPN | SUPERNUS PHARMACEUTICALS INC | $11,713,000 | +33.6% | 575,000 | 0.0% | 0.72% | +46.3% | |
| VCYT | VERACYTE INC | $11,328,000 | -6.8% | 2,252,000 | 0.0% | 0.69% | +1.9% | |
| HASI | Buy | HANNON ARMSTRONG SUST INFR C | $10,966,000 | +56.3% | 507,667 | +39.1% | 0.67% | +71.2% |
| ACAD | ACADIA PHARMACEUTICALS INC | $10,864,000 | +16.1% | 334,700 | 0.0% | 0.66% | +27.2% | |
| CSIQ | CANADIAN SOLAR INC | $9,072,000 | -21.6% | 600,000 | 0.0% | 0.56% | -14.1% | |
| MDVN | Sell | MEDIVATION INC | $9,045,000 | -59.4% | 150,000 | -69.0% | 0.55% | -55.5% |
| TSLA | Sell | TESLA MTRS INC | $8,491,000 | -66.5% | 40,000 | -63.7% | 0.52% | -63.3% |
| AYR | AIRCASTLE LTD | $8,383,000 | -12.1% | 428,600 | 0.0% | 0.51% | -3.8% | |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $8,142,000 | +0.2% | 249,600 | 0.0% | 0.50% | +9.7% | |
| WVE | New | WAVE LIFE SCIENCES LTD | $7,862,000 | – | 380,000 | +100.0% | 0.48% | – |
| ONCE | SPARK THERAPEUTICS INC | $7,670,000 | +73.3% | 150,000 | 0.0% | 0.47% | +89.9% | |
| TSRO | Sell | TESARO INC | $7,565,000 | -4.5% | 90,000 | -50.0% | 0.46% | +4.5% |
| KITE | KITE PHARMA INC | $7,430,000 | +8.9% | 148,600 | 0.0% | 0.46% | +19.4% | |
| ESSA PHARMA INC | $7,370,000 | -5.8% | 2,719,410 | 0.0% | 0.45% | +3.2% | ||
| UFS | Sell | DOMTAR CORP | $7,002,000 | -56.8% | 200,000 | -50.0% | 0.43% | -52.7% |
| CSLT | CASTLIGHT HEALTH INCcl b | $6,766,000 | +18.9% | 1,708,600 | 0.0% | 0.41% | +30.2% | |
| GWPH | GW PHARMACEUTICALS PLCads | $6,730,000 | +26.9% | 73,500 | 0.0% | 0.41% | +39.2% | |
| XNCR | XENCOR INC | $6,533,000 | +41.5% | 344,000 | 0.0% | 0.40% | +55.0% | |
| CERN | CERNER CORP | $6,341,000 | +10.7% | 108,200 | 0.0% | 0.39% | +21.2% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $5,835,000 | -5.7% | 75,000 | 0.0% | 0.36% | +3.2% | |
| STML | STEMLINE THERAPEUTICS INC | $5,764,000 | +45.3% | 851,400 | 0.0% | 0.35% | +59.0% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $5,681,000 | +14.9% | 125,000 | 0.0% | 0.35% | +26.1% | |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $5,366,000 | +20.6% | 265,000 | +7.5% | 0.33% | +31.7% |
| MCRB | SERES THERAPEUTICS INC | $5,177,000 | +9.4% | 178,200 | 0.0% | 0.32% | +20.1% | |
| SAGE | SAGE THERAPEUTICS INC | $5,122,000 | -6.0% | 170,000 | 0.0% | 0.31% | +2.6% | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $4,994,000 | -11.6% | 90,000 | 0.0% | 0.31% | -3.2% | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $4,275,000 | -22.7% | 87,400 | 0.0% | 0.26% | -15.2% | |
| PRTA | PROTHENA CORP PLC | $4,195,000 | -15.1% | 120,000 | 0.0% | 0.26% | -6.9% | |
| AGTC | APPLIED GENETIC TECHNOL CORP | $3,944,000 | +1.1% | 279,100 | 0.0% | 0.24% | +10.6% | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $3,645,000 | -24.2% | 250,000 | 0.0% | 0.22% | -17.1% | |
| JUNO | JUNO THERAPEUTICS INC | $3,460,000 | +0.9% | 90,000 | 0.0% | 0.21% | +10.4% | |
| VYGR | VOYAGER THERAPEUTICS INC | $3,297,000 | +25.9% | 300,000 | 0.0% | 0.20% | +38.4% | |
| TGTX | TG THERAPEUTICS INC | $3,258,000 | -28.9% | 537,600 | 0.0% | 0.20% | -22.3% | |
| INCY | INCYTE CORP | $3,199,000 | +10.3% | 40,000 | 0.0% | 0.20% | +21.0% | |
| CEMP | CEMPRA INC | $3,049,000 | -5.9% | 184,900 | 0.0% | 0.19% | +3.3% | |
| RGEN | REPLIGEN CORP | $3,010,000 | +2.0% | 110,000 | 0.0% | 0.18% | +11.5% | |
| VRTX | VERTEX PHARMACEUTICALS INC | $2,976,000 | +8.2% | 34,600 | 0.0% | 0.18% | +18.2% | |
| GLPG | GALAPAGOS NVspon adr | $2,884,000 | +32.6% | 52,000 | 0.0% | 0.18% | +44.3% | |
| NTUS | NATUS MEDICAL INC DEL | $2,835,000 | -1.6% | 75,000 | 0.0% | 0.17% | +7.5% | |
| EPZM | EPIZYME INC | $2,816,000 | -15.5% | 275,000 | 0.0% | 0.17% | -7.5% | |
| CDTX | CIDARA THERAPEUTICS INC | $2,722,000 | -18.8% | 264,000 | 0.0% | 0.17% | -10.7% | |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $2,737,000 | +4.6% | 165,000 | 0.0% | 0.17% | +14.4% | |
| SYRS | New | SYROS PHARMACEUTICALS INC | $2,723,000 | – | 150,000 | +100.0% | 0.17% | – |
| TTPH | New | TETRAPHASE PHARMACEUTICALS I | $2,580,000 | – | 600,000 | +100.0% | 0.16% | – |
| ATRC | ATRICURE INC | $2,543,000 | -16.0% | 180,000 | 0.0% | 0.16% | -7.7% | |
| CHRS | COHERUS BIOSCIENCES INC | $2,449,000 | -20.4% | 145,000 | 0.0% | 0.15% | -12.8% | |
| PTI | PROTEOSTASIS THERAPEUTICS IN | $2,426,000 | +25.8% | 200,000 | 0.0% | 0.15% | +37.0% | |
| OMED | ONCOMED PHARMACEUTICALS INC | $2,339,000 | +21.8% | 190,000 | 0.0% | 0.14% | +33.6% | |
| TCON | TRACON PHARMACEUTICALS INC | $2,268,000 | -37.3% | 517,700 | 0.0% | 0.14% | -31.2% | |
| TNDM | Buy | TANDEM DIABETES CARE INC | $2,074,000 | +51.8% | 275,000 | +75.4% | 0.13% | +67.1% |
| ARAY | New | ACCURAY INC | $1,589,000 | – | 306,200 | +100.0% | 0.10% | – |
| CTMX | CYTOMX THERAPEUTICS INC | $1,532,000 | -20.8% | 150,000 | 0.0% | 0.09% | -13.0% | |
| IMDZ | IMMUNE DESIGN CORP | $1,469,000 | -37.2% | 180,000 | 0.0% | 0.09% | -31.3% | |
| ZSAN | ZOSANO PHARMA CORP | $1,173,000 | -42.6% | 888,300 | 0.0% | 0.07% | -36.8% | |
| DRNA | DICERNA PHARMACEUTICALS INC | $1,131,000 | -44.0% | 377,000 | 0.0% | 0.07% | -38.9% | |
| SEP | Buy | SPECTRA ENERGY PARTNERS LP | $811,000 | +75.5% | 17,200 | +79.0% | 0.05% | +92.3% |
| HTGC | Buy | HERCULES CAPITAL INC | $795,000 | +59.0% | 64,000 | +53.8% | 0.05% | +75.0% |
| JCI | Buy | JOHNSON CTLS INC | $673,000 | +56.9% | 15,200 | +38.2% | 0.04% | +70.8% |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $677,000 | +61.6% | 25,800 | +61.2% | 0.04% | +78.3% |
| BEP | Buy | BROOKFIELD RENEWABLE PARTNERpartnership unit | $596,000 | +113.6% | 20,000 | +115.1% | 0.04% | +125.0% |
| BDN | Buy | BRANDYWINE RLTY TRsh ben int new | $580,000 | +50.3% | 34,500 | +25.5% | 0.04% | +59.1% |
| CPPL | Buy | COLUMBIA PIPELINE PARTNERS L | $533,000 | +76.5% | 35,500 | +71.6% | 0.03% | +94.1% |
| NYLD | Buy | NRG YIELD INCcl c | $514,000 | +80.4% | 33,000 | +65.0% | 0.03% | +93.8% |
| ETN | Buy | EATON CORP PLC | $346,000 | +31.6% | 5,800 | +38.1% | 0.02% | +40.0% |
| BBN | Sell | BLACKROCK TAX MUNICPAL BD TR | $328,000 | -1.2% | 13,450 | -6.9% | 0.02% | +5.3% |
| ABB | Buy | ABB LTDsponsored adr | $307,000 | +26.3% | 15,500 | +24.0% | 0.02% | +35.7% |
| LPT | Buy | LIBERTY PPTY TRsh ben int | $290,000 | +57.6% | 7,300 | +32.7% | 0.02% | +80.0% |
| WELL | WELLTOWER INC | $274,000 | +9.6% | 3,600 | 0.0% | 0.02% | +21.4% | |
| ERIC | Buy | ERICSSONadr b sek 10 | $276,000 | +34.0% | 36,000 | +75.6% | 0.02% | +41.7% |
| NSC | Buy | NORFOLK SOUTHERN CORP | $255,000 | +33.5% | 3,000 | +30.4% | 0.02% | +45.5% |
| APU | Buy | AMERIGAS PARTNERS L Punit l p int | $210,000 | +92.7% | 4,500 | +80.0% | 0.01% | +116.7% |
| BG | Buy | BUNGE LIMITED | $201,000 | +60.8% | 3,400 | +54.5% | 0.01% | +71.4% |
| LXP | Buy | LEXINGTON REALTY TRUST | $147,000 | +34.9% | 14,500 | +14.2% | 0.01% | +50.0% |
| VTR | VENTAS INC | $124,000 | +15.9% | 1,700 | 0.0% | 0.01% | +33.3% | |
| BAB | Sell | POWERSHARES ETF TR IIbuild amer etf | $133,000 | -15.3% | 4,211 | -19.2% | 0.01% | -11.1% |
| WBK | Buy | WESTPAC BKG CORPsponsored adr | $121,000 | +86.2% | 5,500 | +96.4% | 0.01% | +75.0% |
| TESLA MTRS INCnote 0.250% 3/0 | $89,000 | -2.2% | 100,000 | 0.0% | 0.01% | 0.0% | ||
| NATI | NATIONAL INSTRS CORP | $77,000 | -8.3% | 2,800 | 0.0% | 0.01% | 0.0% | |
| TERP | TERRAFORM PWR INC | $51,000 | +27.5% | 4,650 | 0.0% | 0.00% | +50.0% | |
| GLBL | TERRAFORM GLOBAL INCcl a | $28,000 | +33.3% | 8,700 | 0.0% | 0.00% | +100.0% | |
| RMR | RMR GROUP INCcl a | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – | |
| SE | Exit | SPECTRA ENERGY CORP | $0 | – | -1,000 | -100.0% | -0.00% | – |
| DLR | Exit | DIGITAL RLTY TR INC | $0 | – | -650 | -100.0% | -0.00% | – |
| BIP | Exit | BROOKFIELD INFRAST PARTNERSlp int unit | $0 | – | -2,000 | -100.0% | -0.01% | – |
| SYK | Exit | STRYKER CORP | $0 | – | -1,000 | -100.0% | -0.01% | – |
| GOV | Exit | GOVERNMENT PPTYS INCOME TR | $0 | – | -7,000 | -100.0% | -0.01% | – |
| INFI | Exit | INFINITY PHARMACEUTICALS INC | $0 | – | -246,700 | -100.0% | -0.07% | – |
| Exit | ACCURAY INC | $0 | – | -306,200 | -100.0% | -0.10% | – | |
| QURE | Exit | UNIQURE NV | $0 | – | -174,900 | -100.0% | -0.12% | – |
| INSM | Exit | INSMED INC | $0 | – | -210,000 | -100.0% | -0.15% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -332,300 | -100.0% | -0.36% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -393,000 | -100.0% | -0.45% | – |
| LGND | Exit | LIGAND PHARMACEUTICALS INC | $0 | – | -80,000 | -100.0% | -0.48% | – |
| ABY | Exit | ABENGOA YIELD PLC | $0 | – | -905,000 | -100.0% | -0.90% | – |
| IMPV | Exit | IMPERVA INC | $0 | – | -321,900 | -100.0% | -0.91% | – |
| QLIK | Exit | QLIK TECHNOLOGIES INC | $0 | – | -1,005,800 | -100.0% | -1.62% | – |
| RHT | Exit | RED HAT INC | $0 | – | -621,600 | -100.0% | -2.59% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 43 | Q2 2024 | 3.2% |
| PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
| ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
| REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
| VERACYTE INC | 41 | Q2 2024 | 1.5% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
| COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
| BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
| Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
| Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
| Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
| Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
| MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
| Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
| Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-08-13 |
| SC 13G/A | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.